NeuroAiD™II  awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)


Bringing Innovative Solutions to Healthcare Practitioners


Bringing Innovative Solutions to Healthcare Practitioners.

A Focus on Neurology

Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide. 

Our products are developed by Moleac with scientific excellence and evidence-based approach.

Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide. 

Challenging the Boundaries Of The Possible.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

Patients taking NeuroAid yearly

Awards

Countries with Exclusive Partnership

Shaping the Future of Neurological Care

Latest News

Jun 25 2026
News

Advancing Brain Injury Care: Highlights from Labuan Bajo, Indonesia

Against the unique backdrop of Labuan Bajo and the Komodo Islands in Indonesia, healthcare professionals came together to discuss the management of brain injuries and...
Jun 25 2026
News

How Telemedicine Is Transforming Global Neurosurgical Care: Insights from a New Scoping Review

📰🧠🔬 NEUROSURGERY STUDY HIGHLIGHTS – Unlocking global neurosurgery: how telemedicine addresses unmet needs and future prospects – a scoping review by Sierra...
Jun 17 2026
News

Thank You for Joining Moleac’s AACNS 2026 Lunch Symposium

Thank you for joining us at the Moleac Lunch Symposium at AACNS in Manila.

Jun 16 2026
News

Meet the Moleac Team at AACNS 2026 – Visit Us at Booth #28

Our team is at the 18ᵗʰ Asian Australasian Congress of Neurological Surgeons (AACNS) in Manila!

Jun 16 2026
News

Advancing Alzheimer’s Disease Care Through Scientific Collaboration in Türkiye

Advancing the management of Alzheimer’s disease through scientific collaboration.

Jun 12 2026
News

Join Moleac at AACNS 2026: Unlocking Recovery Potential in Brain and Spine Rehabilitation

Join us at the 18ᵗʰ Asian Australasian Congress of Neurological Surgeons (AACNS) in Manila for our symposium on Unlocking Recovery Potential: Advances in Brain and...
Jun 10 2026
News

Meet Moleac at AACNS 2026: Advancing Brain and Spinal Injury Recovery

Moleac is attending the 18ᵗʰ Asian Australasian Congress of Neurological Surgeons (AACNS) from 15-18 June 2026, in Manila (Philippines).

Jun 10 2026
News

Join the ASAP Webinar: Exploring Sex Differences in Stroke

Moleac is delighted to support the upcoming webinar on Sex Differences in Stroke hosted by the Asian Stroke Advisory Panel (ASAP) gathering neurology experts from...
Jun 05 2026
News

Looking Back at Our ESOC 2026 Symposium: Unlocking Recovery Potential in Post-Stroke Neurorehabilitation

A look back at our symposium, “Unlocking Recovery Potential: Advances in Post-Stroke Neurorehabilitation”, held during the European Stroke Organisation...
Jun 02 2026
News

Meet Moleac at AACNS 2026 in Manila – Visit Us at Booth #28

Moleac will be present at the 18ᵗʰ Asian Australasian Congress of Neurological Surgeons (AACNS), taking place from 15–18 June 2026 in Manila, Philippines.